BDBM643761 US12351590, Compound 1-13::US20240002404, Compound in Embodiment 2

SMILES CN([C@@H]1CCc2cc(nn2C1)C#N)c1ncnc2[nH]ccc12

InChI Key InChIKey=YSIFKJPIAGMGIG-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 643761   

TargetTyrosine-protein kinase JAK1(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 1nMAssay Description:JAK1(h) was incubated with 20 mM Tris/HCl pH 7.5, 0.2 mM EDTA, 500 μM MGEEPLYWSFPAKKK, 10 mM magnesium acetate and [γ-33P]-ATP (activity an...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 8nMAssay Description:JAK2(h) was incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 100 μM KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC, 10 mM magnesium acetate and [γ-33...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 118nMAssay Description:JAK3(h) was incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 500 μM GGEEEEYFELVKKKK, 10 mM magnesium acetate and [γ-33P]-ATP (activity and con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 15nMAssay Description:TYK2(h) was incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM GGMEDIYFEFMGGKKK, 10 mM magnesium acetate and [γ-33P]-ATP (activity and co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
In Depth
Date in BDB:
10/23/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
In Depth
Date in BDB:
10/23/2025
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 118nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Guangzhou Joyo Pharmatech Co.

US Patent
LigandPNGBDBM643761(US20240002404, Compound in Embodiment 2 | US123515...)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
Go to US Patent